Articles tagged with Drug Studies
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A study found that fewer than half of US clinical trials comply with the law on reporting results, with non-industry sponsored trials most likely to breach. Trials with industry sponsors are more likely to report results on time, but progress has stalled since July 2018.
Researchers at UC Riverside are targeting cancer-causing genes Mcl-1 and Bfl-1 for novel therapies in melanoma and lung cancers. They aim to develop potent agents that can help tackle chemotherapy-resistant cancers.
Clinical trials suggest that psychedelic-assisted psychotherapy is more effective than traditional therapy alone in treating PTSD. The combination of MDMA and traditional psychotherapy has shown promising results, with patients experiencing temporary adverse reactions not requiring additional medical intervention.
The MND-SMART trial is a comprehensive clinical study that seeks to find treatments for motor neurone disease (MND), a progressive condition affecting the nervous system. The trial will involve over 1,500 participants and test multiple treatments against a shared placebo group.
A systematic review found that albendazole (ALB) and praziquantel (PZQ) are effective in treating taeniasis caused by the pork tapeworm. The study analyzed 20 studies, including before-after designs and controlled trials, and reported cure rates ranging from 52% to 99.5%.
As demographics change, spina bifida patients' needs are evolving, highlighting the need for research on quality of life and social determinants. The article discusses emerging trends in spina bifida care and the importance of addressing health disparities among minority populations.
A recent investigation by Science found that companies, universities, and institutions are often non-compliant with the requirement to report clinical trial results in a federal database. More than 55% of trials violated this law, yet regulatory agencies have failed to enforce penalties or actions against violators.
A 20-year study found that long-term antipsychotic treatment significantly reduced mortality in people with schizophrenia compared to those without medication. The study also showed no increased risk of hospitalization for cardiovascular disease among those receiving antipsychotic therapy.
Researchers analyzed 20 years of research on intention deactivation and found that completed intentions can sometimes continue to affect people, particularly when reminders or stimuli trigger their retrieval. This effect is often rare but can play a role in learning new routines.
A UK-wide trial has started recruiting patients for a three-year study on preventing falls in people with Parkinson's disease, led by the Royal United Hospitals Bath NHS Foundation Trust and the University of Bristol. The trial will test whether a commonly prescribed dementia drug can prevent debilitating falls and improve patients' qu...
A nationwide Finnish study found that individuals with Alzheimer's disease who took antipsychotic medications had a 29% higher risk of head injuries compared to those who didn't. This is particularly concerning as these patients already have a higher risk of falling and traumatic brain injuries.
A physically and mentally active lifestyle can slow FTD symptoms by providing cognitive resilience to brain degeneration. Research participants with dominant genetic mutations showed slower functional decline in the most active group compared to the least active group.
The study found significant tumor shrinkage in two out of three patients with salivary gland tumors treated with T-DM1. The benefit lasted for at least two years in one patient, suggesting a promising activity for this rare cancer type.
Researchers identified five practices: prepare with intention, listen intently and completely, agree on priorities, connect with the patient's story, and explore emotional cues. These practices aim to improve patient experiences and clinician satisfaction in medicine. The team is now evaluating their effectiveness in clinical settings.
Antipsychotic medications may increase death or cardiopulmonary arrest risk in older hospital patients, particularly those taking first-generation antipsychotics. The study highlights the need for cautious use of these medications to treat delirium and protect patients.
A new set of guidelines for Complex Innovative Trials (CID) aims to improve the quality and efficiency of clinical trials. The recommendations cover stages from trial planning to patient-facing documentation, with the goal of accelerating the development and approval of innovative treatments.
A study by Penn Medicine found that residents of Hispanic neighborhoods are less likely to receive CPR from a bystander and have a lower chance of survival following cardiac arrest. The study analyzed over 27,000 cardiac arrest events and showed a significant disparity in CPR delivery rates between Hispanic and non-Hispanic neighborhoods.
A University of Michigan study found that prompt disposal of leftover medications improved when parents received a disposal packet and tailored online messages. The study suggests that easy disposal and risk education can significantly reduce the number of parents keeping leftover opioids for their children.
A systematic review and meta-analysis found insufficient evidence to determine whether serotonin reuptake inhibitors or trauma-focused psychotherapy are more effective in treating PTSD. The study concludes that clinicians should make shared decisions with patients based on patient preferences regarding treatment characteristics.
A new study published in the Journal of the American Heart Association finds that heavy drinking can cause subclinical heart damage, increasing levels of blood biomarkers associated with inflammation and cardiac wall stretch. Heavy drinkers are more likely to experience cardiovascular disease than non-problem drinkers.
A new drug trial by Monash University Professor Eric Morand shows a statistically-significant reduction in disease activity versus placebo in lupus patients. The TULIP 2 trial found a significant effect in global disease activity measures, including improved skin disease and reduced steroid doses.
A new study shows that blocking the neonatal crystallizable fragment receptor (FcRn) can reduce levels of immunoglobulin G (IgG) and IgG immune complexes, potentially treating autoimmune diseases. The therapy, SYNT001, was well-tolerated in a Phase 1 clinical study.
Researchers found that fenfluramine significantly reduced convulsive seizures in Dravet syndrome patients, with a 62% decrease in seizures per month. The study also showed improvements in seizure-free intervals and parental assessments of child improvement.
A working group of medical organizations analyzed 29 pivotal phase III trials for disease-modifying drugs in MS, finding that patient symptoms and quality of life were often not considered. They suggest improving studies by focusing on patient-reported outcomes and long-term treatment effects.
A randomized controlled trial found that fenfluramine reduced convulsive seizures by 62% in patients with Dravet Syndrome. Low-dose fenfluramine also showed significant reductions in seizure frequency, while side effects were manageable.
A national study found a significant rise in teens taking and overdosing on benzodiazepines, commonly prescribed anxiety medications. The rate of exposure among adolescents increased by 54% between 2000 and 2015, with nearly half of all reported exposures documented as intentional abuse or misuse.
A recent clinical trial found that nilotinib increases dopamine levels and reduces neurotoxic proteins in people with Parkinson's disease. The study also showed potential in halting motor and non-motor decline, making it a promising treatment option.
Researchers found that children with mild to moderate asthma who experienced worsening symptoms had distinct bacterial groups in their upper airways, while those with well-controlled asthma had different bacteria. Altering the airway microbiome could potentially help patients with asthma.
Researchers found that women with poorer quality of life, higher pain and endocrine symptoms, and negative beliefs about medication effectiveness are more likely to stop taking aromatase inhibitors. Patient-reported outcomes can act as biomarkers, predicting non-adherence and informing personalized treatment strategies.
The Physicians Committee awarded Mihael H. Polymeropoulos the Trailblazer Award for his efforts to replace animal tests with human-relevant science. He challenged the FDA's utility of dog studies in drug development and advocated for modern, human-based scientific methods to advance human drug safety.
A new analysis confirms human genomic data can predict success in clinical trials, with genetically supported drug targets twice as likely to be approved. Historically, drugs targeting proteins with amino acid sequence changes linked to the disease have the best chance of approval.
A new study has confirmed that bovine kobuvirus is the causative agent for calf diarrhea in US cattle. The virus was found in four of nine samples tested at the University of Illinois Veterinary Diagnostic Laboratory.
A systematic review and meta-analysis found no conclusive evidence supporting the safety of ivermectin administration among pregnant women. The studies included in the analysis reported some adverse events, but the number of cases was too low to be conclusive.
A phase III clinical trial shows tucatinib significantly improves survival rates in women with HER2+ breast cancer, especially those with brain metastases. The study found nearly tripled one-year progression-free survival and doubled two-year overall survivor compared to standard treatment.
A study found that pharmacy-based transition-of-care models can improve patient satisfaction by educating patients about their medications as they transition out of hospital care. The model also led to a significant drop in hospital readmission rates.
The trial showed that adding tucatinib to capecitabine and trastuzumab improved progression-free and overall survival in advanced HER2-positive breast cancer patients, regardless of whether they had brain metastasis. The treatment combination also increased the overall response rate compared to standard care.
A study by University of Cincinnati researchers found that certain antidepressant medications cause more side effects in children and adolescents with OCD and anxiety disorders. SSRIs were associated with increased rates of agitation, while SNRIs showed no significant link to suicidality.
A study found that more than 25% of lung cancer patients are prescribed medications with potential cardiac risk, and almost 10% take multiple such medications. The researchers argue that these criteria may be excessive and could be too strict, excluding patients who don't pose a cardiac risk.
A new study found that Huntington's disease patients are at risk of therapeutic misconception due to a lack of understanding about clinical trial risks and benefits. Investigators recommend improving patient-doctor communication to address this issue.
Cinnarizine and sodium valproate show promise as preventive agents for pediatric migraine, reducing headache frequency by over 50% compared to placebo. The study suggests these medications may be a new option for children and adolescents with migraine, but long-term safety concerns need further investigation.
A new study found that varenicline tartrate is effective in quitting smoking among adolescents, with a higher rate of long-term success compared to the placebo group. However, it did not prevent relapse. The researchers suggest pairing medication with therapy and behavioral treatments for better results.
A recent review found that aspirin no longer provides a net benefit for primary prevention of cardiovascular disease and cancer, despite its long history of reducing heart attack risk. Aspirin use has decreased in recent years due to the emergence of statins and improved cancer screening technology.
A recent study found that a combination of chemotherapy and immunotherapy caused serious side effects in 32% of older patients enrolled on a leukemia trial. The findings highlight the need for caution when enrolling vulnerable populations in clinical trials.
A study by University of Utah Health found that people with chronic illnesses turn to underground exchanges for medicines and supplies due to affordability and accessibility issues. Many participants donated or traded goods with family, friends, or strangers who couldn't get them through traditional channels.
A pilot study found that limiting food consumption to a 10-hour window per day improved health outcomes in participants with metabolic syndrome. Participants experienced significant weight loss, reduced abdominal fat, and stable blood sugar and insulin levels.
A global clinical trial has demonstrated the safety and effectiveness of an oral medication to treat nonalcoholic steatohepatitis (NASH), a chronic liver disease. The treatment, obeticholic acid, showed the ability to reverse liver scarring in patients most at risk for irreversible liver damage.
A pilot study found that restricting eating to 10 hours a day for 12 weeks improved weight loss and reduced symptoms of metabolic syndrome in individuals at high risk for diabetes. Participants also experienced increased sleep satisfaction and some were able to lower or discontinue medications.
A clinical trial found nilotinib to be safe and tolerable for patients with moderate to advanced Parkinson's disease, but did not show a clinically meaningful benefit. The study, led by Northwestern University, involved 76 participants and tested three doses of the medication over six months.
A new field study in Nepal shows the typhoid vaccine is safe, immunogenic and effective against the disease, with results showing 7 cases out of 20,000 children vaccinated. The study's findings are significant, especially with the recent spread of drug-resistant typhoid, which threatens child health in affected regions.
Young adults who use heavily are more likely to receive medical marijuana cards, a study published in the Journal of Studies on Alcohol and Drugs found. The study analyzed data from California participants aged 18-20 and showed that frequent marijuana use was the primary driver of card acquisition.
Scientists at Salk Institute discovered that metformin activates multiple biochemical switches, including Protein Kinase D and MAPKAPK2, which may explain its health-span-extending effects. The study identified new targets and cellular processes regulated by AMPK, shedding light on the therapeutic benefits of metformin.
A recent study highlights a 'worrying' increase in misuse of gabapentin and baclofen medications in the US, coinciding with a decline in opioid prescriptions. The analysis found significant rises in intentional suspected suicide attempts and hospital admissions related to these non-opioid medications.
A new study found that intravenous levetiracetam, fosphenytoin, and valproate are equally effective in stopping status epilepticus seizures, with each drug working about 45% of the time. The results suggest a major change in clinical practice, recommending increased dosing of commonly used levetiracetam.
The PALM clinical trial found that investigational drugs mAb114 and REGN-EB3 offered lower mortality rates compared to ZMapp, with mortality rates of 35% and 34%, respectively. Early diagnosis and treatment also improved survival chances.
Researchers at Karolinska Institutet discovered that high androgen levels during pregnancy increase the risk of polycystic ovary syndrome (PCOS) in daughters for multiple generations. The study found that altered gene expression and placenta dysfunction contribute to the transmission of PCOS symptoms.
A pharmacy service has been shown to reduce NHS costs by £651 million while improving patient outcomes through enhanced medication adherence. The New Medicine Service, delivered by pharmacists since 2011, supports patients taking new medicines and helps them adhere to their treatment regimens.
A new study published in the British Journal of Clinical Pharmacology found that pharmacist-led interventions can significantly reduce medical risk factors for cardiovascular events. Pharmacist-led interventions included patient education, medication review, and lifestyle modification, resulting in reductions in systolic blood pressure...
A review of randomized controlled trials found that pharmacist-led interventions, such as medication review and patient education, can help prevent cardiovascular disease. Patients who received these interventions experienced significant reductions in systolic blood pressure, hemoglobin A1c, and LDL-cholesterol levels.
A new study has found that levetiracetam, fosphenytoin, and valproate are equally safe and effective in treating patients with refractory status epilepticus. The three drugs were tested on over 380 children and adults, showing similar benefits in stopping seizures and improving responsiveness.
A new study reveals that levetiracetam, fosphenytoin, and valproate are equally safe and effective in treating patients with refractory status epilepticus, a life-threatening condition characterized by prolonged seizures. The three drugs stopped seizures and improved responsiveness in approximately half of the study participants.